Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MRGPRX4 | Q96LA9 | 2/20 | 0.52 |
| ▸ | KCNK3 | O14649 | 6/20 | 0.49 |
| ▸ | KCNK9 | Q9NPC2 | 5/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 3/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.45 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.45 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.45 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | RHOC | P08134 | 1/20 | 0.45 |
| ▸ | RHOA | P61586 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4175364 | 0.88 | KCNK3 (0.49) | MRGPRX4KCNK3KCNK9LMNARAB9A | |
| SCHEMBL13875623 | 0.85 | KCNK3 (0.58) | MRGPRX4KCNK3KCNK9LMNARAB9A | |
| SCHEMBL4191849 | 0.85 | PTGS1 (0.47) | MRGPRX4KCNK3KCNK9TAS1R3TAS1R1 | |
| SCHEMBL1767236 | 0.85 | KCNK3 (0.56) | MRGPRX4KCNK3KCNK9LMNARAB9A | |
| SCHEMBL20846961 | 0.84 | RHOC (0.49) | KCNK3KCNK9LMNARAB9ANPC1 | |
| SCHEMBL22402135 | 0.82 | MAPT (0.51) | KCNK3KCNK9LMNARAB9ANPC1 | |
| SCHEMBL4180259 | 0.82 | ABCC9 (0.48) | LMNARAB9ANPC1TAS1R3TAS1R1 | |
| SCHEMBL20846962 | 0.81 | KCNK3 (0.47) | KCNK3KCNK9LMNARAB9ANPC1 | |
| SCHEMBL29409938 | 0.79 | KCNK3 (0.59) | KCNK3KCNK9LMNARAB9ANPC1 | |
| SCHEMBL12570375 | 0.79 | KCNK3 (0.59) | KCNK3KCNK9LMNARAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090099204-A1 | Amide derivative, insecticide containing the same and method for application thereof as insecticide | MITSUI CHEMICALS, INC. (JP) | 2009-04-16 | — | — | US | disclosed |
| EP-1916236-A1 | AMIDE DERIVATIVE, PESTICIDE CONTAINING SUCH COMPOUND AND USE THEREOF | Mitsui Chemicals, Inc. (JP) | 2008-04-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090099204-A1 | Amide derivative, insecticide containing the same and method for application thereof as insecticide | CYP2E1, GSTA1, CYP2S1 | MRGPRX4 2754/4885KCNK3 504/4885KCNK9 954/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.